<< Read Full Article
<< Read Full Article
Welcome back to the Biotech Mailbag. This week, I'll tackle questions on Middlebrook Pharmaceuticals(MBRK Quote) and Isis Pharmaceuticals(ISIS Quote).
Middlebrook Pharmaceuticals shares soared this week on the FDA approval of Moxatag, the company's proprietary, once-daily formulation of the antibiotic amoxicillin.
The news prompted an email from Neal G., who writes: "Is it me, or is this drug a big nothing? When my kids get strep they take antibiotics once a day." ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.58 | 1,108.86 | 2,175.81 | 32.75 |
Oil *
79.69
|
|
UP
126.74
|
UP
13.23
|
UP
31.21
|
UP
0.74
|
10 Yr
3.28%
SPDR Gold
117.38
|
|
+1.23%
|
+1.21%
|
+1.46%
|
+2.31%
|
Data delayed 20 minutes |
Connect with TheStreet